ClinConnect ClinConnect Logo
Search / Trial NCT07047079

a Patient Navigation-based Preoperative Rehabilitation Exercise Program in Patients Undergoing TKA

Launched by ANNA SUN · Jul 1, 2025

Trial Information

Current as of July 22, 2025

Enrolling by invitation

Keywords

Patient Navigation Preoperative Rehabilitation Exercise Total Knee Arthroplasty

ClinConnect Summary

On the day of admission, after being informed of the study and potential risks, all patients giving written informedconsent will immediately screening period to determine eligibility for study entry.patients who meet the eligibility requirements will be randomized in a single-blindmanner( (data collection personnel) in a 1:1 ratio to receive 3-7 day a patient navigation-based preoperative rehabilitation exercise program or a autonomous preoperative rehabilitation training program.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with knee osteoarthritis (KOA) scheduled to undergo primary unilateral total knee arthroplasty (TKA)
  • Assessed by the attending physician as medically fit to tolerate preoperative rehabilitation exercise, possessing effective communication skills, and capable of cooperating with all required examinations and assessments
  • Assessed as capable (either the patient or their caregiver) of using a smartphone to receive information
  • Exclusion Criteria:
  • Individuals unable to cooperate due to impaired consciousness, cognitive impairment, or similar conditions
  • Concurrent severe comorbidities such as liver cirrhosis, respiratory failure, renal failure, malignant tumors, trauma, etc.
  • History of significant neuromuscular disorders or other joint diseases deemed by the attending physician to affect joint function
  • Hospital admission date \>7 days or \<3 days prior to the scheduled surgery date
  • Currently undergoing systematic lower limb functional exercise training within the past four weeks

About Anna Sun

Anna Sun is a dedicated clinical trial sponsor committed to advancing medical research through the support and oversight of innovative clinical studies. With a focus on ensuring ethical standards, participant safety, and scientific integrity, Anna Sun plays a pivotal role in facilitating the development of new therapies and improving patient outcomes.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Hong zhang

Principal Investigator

research team

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported